Back to CLDX
WELLINGTON MANAGEMENT GROUP LLP → CLDX
WELLINGTON MANAGEMENT GROUP LLP CLDX Position History
Celldex Therapeutics, Inc.
Quarters held
28
Latest value
$3M
Q3 2026
Peak value
$312.4M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $199.4M |
| Q4 2025 | $1.5M |
| Q4 2025 | $94K |
| Q4 2025 | $2.7M |
| Q4 2025 | $13.7M |
| Q4 2025 | $83K |
| Q4 2025 | $1.9M |
| Q1 2026 | $241.5M |
| Q1 2026 | $3.9M |
| Q1 2026 | $143K |
| Q1 2026 | $3.1M |
| Q1 2026 | $18.9M |
| Q1 2026 | $1.6M |
| Q1 2026 | $2.4M |
| Q2 2026 | $312.4M |
| Q2 2026 | $5.3M |
| Q2 2026 | $201K |
| Q2 2026 | $3.9M |
| Q2 2026 | $27.9M |
| Q2 2026 | $2.3M |
| Q2 2026 | $3M |
| Q3 2026 | $300M |
| Q3 2026 | $3.6M |
| Q3 2026 | $175K |
| Q3 2026 | $4.5M |
| Q3 2026 | $32.7M |
| Q3 2026 | $1.9M |
| Q3 2026 | $3M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $3M | 91.5K | — | — |
| Q3 2026 | $1.9M | 57.1K | — | — |
| Q3 2026 | $32.7M | 1.01M | — | — |
| Q3 2026 | $4.5M | 140.1K | — | — |
| Q3 2026 | $175K | 5.4K | — | — |
| Q3 2026 | $3.6M | 112.6K | — | — |
| Q3 2026 | $300M | 9.26M | — | — |
| Q2 2026 | $3M | 80.1K | — | — |
| Q2 2026 | $2.3M | 62.8K | — | — |
| Q2 2026 | $27.9M | 751.0K | — | — |
| Q2 2026 | $3.9M | 105.6K | — | — |
| Q2 2026 | $201K | 5.4K | — | — |
| Q2 2026 | $5.3M | 142.8K | — | — |
| Q2 2026 | $312.4M | 8.40M | — | — |
| Q1 2026 | $2.4M | 74.3K | — | — |
| Q1 2026 | $1.6M | 51.4K | — | — |
| Q1 2026 | $18.9M | 594.6K | — | — |
| Q1 2026 | $3.1M | 99.1K | — | — |
| Q1 2026 | $143K | 4.5K | — | — |
| Q1 2026 | $3.9M | 124.3K | — | — |
| Q1 2026 | $241.5M | 7.61M | — | — |
| Q4 2025 | $1.9M | 71.5K | — | — |
| Q4 2025 | $83K | 3.1K | — | — |
| Q4 2025 | $13.7M | 504.9K | — | — |
| Q4 2025 | $2.7M | 101.0K | — | — |
| Q4 2025 | $94K | 3.5K | — | — |
| Q4 2025 | $1.5M | 54.8K | — | — |
| Q4 2025 | $199.4M | 7.34M | — | — |